Receptor 2: GIP (Glucose-Dependent Insulinotropic Polypeptide) What it does: GIP is the second component retatrutide shares with tirzepatide
Our clinical environment is designed to streamline the IV therapy process, leveraging state-of-the-art equipment and our teams expertise to enhance patient experience and efficacy
Every Zepbound prescription contains tirzepatide
The most common GI side effects of these agents include nausea, vomiting, diarrhoea, abdominal pain, and constipation
Kuroda K, Nakashima J, Kanao K, Kikuchi E, Miyajima A, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Murai M